GNT Eyes Unmet Need As Novel Ischemic Stroke Therapy Moves To Phase III

Breaks New Ground For Korean Pharma

 
• By Jung Won Shin
  
brain scan
GNT Aims To Launch Nelonemdaz In Korea By 2025 • Source: Alamy

More from South Korea

More from Focus On Asia